Thursday, September 08, 2016 11:32:14 AM
According to the agreement, Milost is willing to invest $15 million for working capital needs of PHI Group, which amount can be drawn down in tranches at a minimum of $500,000 until fully utilized. Milost will receive shares of common stock in PHI Group for the equity investments with a price per share on the basis of 10-day’s Volume-Weighted Average at a discount of 20% at the time of issuance. The first drawdown will be made in the next five days.
Henry Fahman, Chairman and CEO of PHI Group, Inc., said, “The funding commitment from Milost will greatly enhance our ability to execute our acquisition program and provide for working capital needs to ensure smooth integration of target companies and implement tailor-made initiatives at the subsidiary level that can generate significant value for our shareholders.” Henry added: “We will prudently balance the mixture of debt and equity to optimize our financing and investment decisions based on the merits of selective transactions.”
Ronald Spratt, President and CEO of Milost Global, Inc., stated, “I am excited to put my money behind Henry Fahman, CEO of PHI Group, Inc. It is our plan to support Henry's efforts at this juncture to ensure that PHI's business plan is fully funded. We continue to look for companies like PHI, where there will be good use of our capital.”
Nigel Buxton, CFO of Milost Global, Inc., commented, “This investment presents an important opportunity for both PHI Group Inc. and Milost Global Inc. to actively participate in the field of new acquisitions.”
Recent PHIL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2024 10:05:47 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:00:09 PM
- US Airforce Contract Awarded to Epazz, Inc. (OTC Pink: EPAZ) • InvestorsHub NewsWire • 12/14/2023 11:48:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 08:40:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:15:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 09:33:15 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:10:38 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:30:15 PM
- Airbus, PHI Group Sign Deal for 28 Helicopters • Dow Jones News • 09/12/2023 01:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2023 12:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 03:30:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 09:00:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:45:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM